A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
Clinical trial NCT03356639 · COMPLETED
Trial details
- NCT number
- NCT03356639
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-22
- Primary completion
- 2018-05-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.